Peter P. De Deyn - Publications

Affiliations: 
Universiteit Antwerpen (Belgium) 
Area:
Toxicology, Neuroscience Biology

239 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Marreiro A, Van Kolen K, Sousa C, Temmerman L, Vasconcelos B, Crespo-Rodriguez R, van Weering JRT, Van Dam D, De Deyn PP, Apetri A, Schoofs L, Mercken MH. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils. Bmc Molecular and Cell Biology. 21: 81. PMID 33183222 DOI: 10.1186/s12860-020-00320-y  0.48
2020 Koçoğlu C, Gossye H, Dillen L, Van Mossevelde S, De Bleecker JL, Vandenberghe R, De Deyn PP, Sleegers K, Cras P, Engelborghs S, Van Broeckhoven C, van der Zee J. No association of CpG SNP rs9357140 with onset age in Belgian C9orf72 repeat expansion carriers. Neurobiology of Aging. PMID 32921502 DOI: 10.1016/j.neurobiolaging.2020.07.021  0.52
2020 Vermeiren Y, Hirschberg Y, Mertens I, De Deyn PP. Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective. Frontiers in Neurology. 11: 595. PMID 32760338 DOI: 10.3389/fneur.2020.00595  0.52
2020 Janssens J, Vermeiren Y, van Faassen M, van der Ley C, Kema IP, De Deyn PP. Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum. Neurochemical Research. PMID 32130630 DOI: 10.1007/s11064-020-03002-5  0.52
2019 Van Dam D, De Deyn PP. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study? Expert Opinion On Drug Discovery. 1-3. PMID 31592694 DOI: 10.1080/17460441.2020.1676719  0.48
2019 Willemse EAJ, Vermeiren Y, Garcia-Ayllon MS, Bridel C, De Deyn PP, Engelborghs S, van der Flier WM, Jansen EEW, Lopez-Font IB, Mendes V, Manadas B, de Roeck N, Saez-Valero J, Struys EA, Vanmechelen E, et al. Pre-analytical stability of novel cerebrospinal fluid biomarkers. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 31348908 DOI: 10.1016/j.cca.2019.07.024  0.52
2019 Roth L, der Donckt CV, Veseli BE, Van Dam D, De Deyn PP, Martinet W, Herman AG, De Meyer GRY. Nitric oxide donor molsidomine favors features of atherosclerotic plaque stability and reduces myocardial infarction in mice. Vascular Pharmacology. PMID 31085310 DOI: 10.1016/j.vph.2019.05.001  0.48
2019 Janssens J, Atmosoerodjo SD, Vermeiren Y, Absalom AR, den Daas I, De Deyn PP. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient. Neurochemistry International. PMID 31034914 DOI: 10.1016/j.neuint.2019.04.015  0.52
2019 Janssens J, Crans RAJ, Van Craenenbroeck K, Vandesompele J, Stove CP, Van Dam D, De Deyn PP. Evaluating the applicability of mouse SINEs as an alternative normalization approach for RT-qPCR in brain tissue of the APP23 model for Alzheimer's disease. Journal of Neuroscience Methods. PMID 30849434 DOI: 10.1016/j.jneumeth.2019.03.005  0.48
2018 Dekker AD, Vermeiren Y, Beugelsdijk G, Schippers M, Hassefras L, Eleveld J, Grefelman S, Fopma R, Bomer-Veenboer M, Oosterling GDE, Scholten E, Tollenaere M, Van Goethem G, Zu Eulenburg C, Coppus AMW, ... De Deyn PP, et al. [The behavioral and psychological symptoms of dementia in down syndrome (BPSD-DS) scale: comprehensive assessment of psychopathology in down syndrome]. Tijdschrift Voor Gerontologie En Geriatrie. PMID 30238286 DOI: 10.1007/s12439-018-0262-8  0.52
2018 Lambotte D, De Donder L, De Roeck EE, Hoeyberghs LJ, van der Vorst A, Duppen D, Van der Elst M, Fret B, Dury S, Smetcoren AS, Kardol MJM, Engelborghs S, De Deyn PP, De Witte N, Schols JMGA, et al. Randomized controlled trial to evaluate a prevention program for frail community-dwelling older adults: a D-SCOPE protocol. Bmc Geriatrics. 18: 194. PMID 30149798 DOI: 10.1186/s12877-018-0875-3  0.52
2018 Missault S, Anckaerts C, Blockx I, Deleye S, Van Dam D, Barriche N, De Pauw G, Aertgeerts S, Valkenburg F, De Deyn PP, Verhaeghe J, Wyffels L, Van der Linden A, Staelens S, Verhoye M, et al. Neuroimaging of subacute brain inflammation and microstructural changes predicts long-term functional outcome after experimental traumatic brain injury. Journal of Neurotrauma. PMID 30032713 DOI: 10.1089/neu.2018.5704  0.48
2018 Perrone F, Cacace R, Van Mossevelde S, Van den Bossche T, De Deyn PP, Cras P, Engelborghs S, van der Zee J, Van Broeckhoven C. Genetic screening in early-onset dementia patients with unclear phenotype: relevance for clinical diagnosis. Neurobiology of Aging. PMID 29859640 DOI: 10.1016/j.neurobiolaging.2018.04.015  0.52
2018 Dekker AD, Vermeiren Y, Carmona-Iragui M, Benejam B, Videla L, Gelpi E, Aerts T, Van Dam D, Fernández S, Lleó A, Videla S, Sieben A, Martin JJ, Blesa R, ... ... De Deyn PP, et al. Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 99-111. PMID 29780859 DOI: 10.1016/j.dadm.2017.11.001  0.52
2018 Dekker AD, Sacco S, Carfi A, Benejam B, Vermeiren Y, Beugelsdijk G, Schippers M, Hassefras L, Eleveld J, Grefelman S, Fopma R, Bomer-Veenboer M, Boti M, Oosterling GDE, Scholten E, ... ... De Deyn PP, et al. The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome. Journal of Alzheimer's Disease : Jad. PMID 29689719 DOI: 10.3233/JAD-170920  0.52
2018 Vermeiren Y, Janssens J, Van Dam D, De Deyn PP. Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes. Frontiers in Neuroscience. 12: 185. PMID 29615862 DOI: 10.3389/fnins.2018.00185  0.52
2018 De Roeck A, Duchateau L, Van Dongen J, Cacace R, Bjerke M, Van den Bossche T, Cras P, Vandenberghe R, De Deyn PP, Engelborghs S, Van Broeckhoven C, Sleegers K. An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer's disease. Acta Neuropathologica. PMID 29589097 DOI: 10.1007/s00401-018-1841-z  0.52
2018 Janssens J, Vermeiren Y, Fransen E, Aerts T, Van Dam D, Engelborghs S, De Deyn PP. Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 172-181. PMID 29552632 DOI: 10.1016/j.dadm.2018.01.002  0.52
2018 Vloeberghs R, Opmeer EM, De Deyn PP, Engelborghs S, De Roeck EE. [Apathy, depression and cognitive functioning in patients with MCI and dementia]. Tijdschrift Voor Gerontologie En Geriatrie. PMID 29488192 DOI: 10.1007/s12439-018-0248-6  0.52
2018 van der Zee S, Vermeiren Y, Fransen E, Van Dam D, Aerts T, Gerritsen MJ, Spikman JM, van Laar T, De Deyn PP. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease. Journal of Parkinson's Disease. 8: 71-84. PMID 29480224 DOI: 10.3233/JPD-171228  0.52
2018 Dury S, Dierckx E, van der Vorst A, Van der Elst M, Fret B, Duppen D, Hoeyberghs L, De Roeck E, Lambotte D, Smetcoren AS, Schols J, Kempen G, Zijlstra GAR, De Lepeleire J, Schoenmakers B, ... ... De Deyn PP, et al. Detecting frail, older adults and identifying their strengths: results of a mixed-methods study. Bmc Public Health. 18: 191. PMID 29378540 DOI: 10.1186/s12889-018-5088-3  0.52
2017 Mertens JC, Leenaerts D, Brouns R, Engelborghs S, Ieven M, De Deyn PP, Lambeir AM, Hendriks D. Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood-brain barrier dysfunction. Journal of Thrombosis and Haemostasis : Jth. PMID 29194929 DOI: 10.1111/jth.13914  0.52
2017 Smetcoren AS, Dury S, De Donder L, Dierckx E, De Witte N, Engelborghs S, De Deyn PP, van der Vorst A, Van der Elst M, Lambotte D, Hoeyberghs L, Fret B, Duppen D, De Roeck E, Kardol M, et al. [Detection and prevention in later life: risk profiles for physical, psychological, social and environmental frailty.] Tijdschrift Voor Gerontologie En Geriatrie. PMID 29181776 DOI: 10.1007/s12439-017-0241-5  0.52
2017 Van Erum J, Van Dam D, De Deyn PP. Sleep and Alzheimer's disease: A pivotal role for the suprachiasmatic nucleus. Sleep Medicine Reviews. PMID 29102282 DOI: 10.1016/j.smrv.2017.07.005  0.48
2017 Versijpt J, Tant M, Beyer I, Bier JC, Cras P, De Deyn PP, De Wit P, Deryck O, Hanseeuw B, Lambert M, Lemper JC, Mormont E, Petrovic M, Picard G, Salmon E, et al. Alzheimer's disease and driving: review of the literature and consensus guideline from Belgian dementia experts and the Belgian road safety institute endorsed by the Belgian Medical Association. Acta Neurologica Belgica. PMID 28983881 DOI: 10.1007/s13760-017-0840-5  0.52
2017 Raj D, Yin Z, Breur M, Doorduin J, Holtman IR, Olah M, Mantingh-Otter IJ, Van Dam D, De Deyn PP, den Dunnen W, Eggen BJL, Amor S, Boddeke E. Increased White Matter Inflammation in Aging- and Alzheimer's Disease Brain. Frontiers in Molecular Neuroscience. 10: 206. PMID 28713239 DOI: 10.3389/fnmol.2017.00206  0.48
2017 Dekker AD, Vermeiren Y, Albac C, Lana-Elola E, Watson-Scales S, Gibbins D, Aerts T, Van Dam D, Fisher EMC, Tybulewicz VLJ, Potier MC, De Deyn PP. Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models. Neurobiology of Disease. PMID 28624415 DOI: 10.1016/j.nbd.2017.06.007  0.52
2017 Van Mossevelde S, van der Zee J, Gijselinck I, Sleegers K, De Bleecker J, Sieben A, Vandenberghe R, Van Langenhove T, Baets J, Deryck O, Santens P, Ivanoiu A, Willems C, Bäumer V, Van den Broeck M, ... ... De Deyn PP, et al. Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion. Jama Neurology. PMID 28192553 DOI: 10.1001/jamaneurol.2016.4847  0.52
2016 Wostyn P, Van Dam D, Audenaert K, De Deyn PP. Do repetitive Valsalva maneuvers reduce glymphatic clearance? Annals of Neurology. PMID 28019646 DOI: 10.1002/ana.24851  0.48
2016 Vermeiren Y, De Deyn PP. Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story. Neurochemistry International. PMID 27899296 DOI: 10.1016/j.neuint.2016.11.009  0.52
2016 Dekens DW, Naudé PJ, Engelborghs S, Vermeiren Y, Van Dam D, Oude Voshaar RC, Eisel UL, De Deyn PP. Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression. Journal of Alzheimer's Disease : Jad. PMID 27716662 DOI: 10.3233/JAD-160330  0.52
2016 Portelius E, Durieu E, Bodin M, Cam M, Pannee J, Leuxe C, Mabondzo A, Oumata N, Galons H, Lee JY, Chang YT, Stϋber K, Koch P, Fontaine G, Potier MC, ... ... De Deyn P, et al. Specific Triazine Herbicides Induce Amyloid-β42 Production. Journal of Alzheimer's Disease : Jad. PMID 27589520 DOI: 10.3233/JAD-160310  0.52
2016 Wostyn P, De Groot V, Van Dam D, Audenaert K, Killer HE, De Deyn PP. Age-related macular degeneration, glaucoma and Alzheimer's disease: amyloidogenic diseases with the same glymphatic background? Cellular and Molecular Life Sciences : Cmls. PMID 27572287 DOI: 10.1007/s00018-016-2348-1  0.52
2016 Somers C, Struyfs H, Goossens J, Niemantsverdriet E, Luyckx J, De Roeck N, De Roeck E, De Vil B, Cras P, Martin JJ, De Deyn PP, Bjerke M, Engelborghs S. A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium. Journal of Alzheimer's Disease : Jad. 54: 383-95. PMID 27567807 DOI: 10.3233/JAD-151097  0.52
2016 Baerts L, Brouns R, Kehoe K, Verkerk R, Engelborghs S, De Deyn PP, Hendriks D, De Meester I. Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity. Translational Stroke Research. PMID 27561653 DOI: 10.1007/s12975-016-0493-3  0.52
2016 Crosiers D, Verstraeten A, Wauters E, Engelborghs S, Peeters K, Mattheijssens M, De Deyn PP, Theuns J, Van Broeckhoven C, Cras P. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort. Neuroscience Letters. PMID 27397011 DOI: 10.1016/j.neulet.2016.07.008  0.52
2016 Vermeiren Y, Janssens J, Aerts T, Martin JJ, Sieben A, Van Dam D, De Deyn PP. Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27314528 DOI: 10.3233/JAD-160320  0.52
2016 Dury S, De Roeck E, Duppen D, Fret B, Hoeyberghs L, Lambotte D, Van der Elst M, van der Vorst A, Schols J, Kempen G, Rixt GA, De Lepeleire J, Schoenmakers B, Kardol T, De Witte N, ... ... De Deyn PP, et al. Identifying frailty risk profiles of home-dwelling older people: focus on sociodemographic and socioeconomic characteristics. Aging & Mental Health. 1-9. PMID 27267783 DOI: 10.1080/13607863.2016.1193120  0.52
2016 Van Dam D, Vermeiren Y, Dekker AD, Naudé PJ, De Deyn PP. Neuropsychiatric disturbances in Alzheimer's disease: what have we learned from neuropathological studies? Current Alzheimer Research. PMID 27137218  0.52
2016 Wostyn P, De Groot V, Van Dam D, Audenaert K, De Deyn PP. The translaminar pressure difference as an index for neurotoxic burden in the anterior part of the optic nerve. Eye (London, England). PMID 27080485 DOI: 10.1038/eye.2016.73  0.48
2016 Wostyn P, De Groot V, Van Dam D, Audenaert K, De Deyn PP. A General Decline in Cerebrospinal Fluid Flow: An Overlooked Risk Factor for Glaucoma? Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 36: 227-8. PMID 27049823 DOI: 10.1097/WNO.0000000000000378  0.52
2016 Verheijen J, Van den Bossche T, van der Zee J, Engelborghs S, Sanchez-Valle R, Lladó A, Graff C, Thonberg H, Pastor P, Ortega-Cubero S, Pastor MA, Benussi L, Ghidoni R, Binetti G, Clarimon J, ... ... De Deyn PP, et al. A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's disease. Acta Neuropathologica. PMID 27026413 DOI: 10.1007/s00401-016-1566-9  0.52
2016 Wostyn P, De Groot V, Van Dam D, Audenaert K, De Deyn PP. A general decline in cerebrospinal fluid flow and optic nerve compartmentation: are these sequential steps leading to toxicity in normal-tension glaucoma? Acta Ophthalmologica. 94: e242-3. PMID 26843452 DOI: 10.1111/aos.12979  0.48
2016 De Roeck E, Ponjaert-Kristoffersen I, Bosmans M, De Deyn PP, Engelborghs S, Dierckx E. Are depressive symptoms in mild cognitive impairment predictive of conversion to dementia? International Psychogeriatrics / Ipa. 28: 921-8. PMID 26778529 DOI: 10.1017/S1041610215002409  0.52
2016 Wostyn P, De Groot V, Van Dam D, Audenaert K, Killer HE, De Deyn PP. Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertension. Clinical & Experimental Optometry. 99: 213-8. PMID 26691953 DOI: 10.1111/cxo.12332  0.48
2016 Janssen L, Keppens C, De Deyn PP, Van Dam D. Late age increase in soluble amyloid-beta levels in the APP23 mouse model despite steady-state levels of amyloid-beta-producing proteins. Biochimica Et Biophysica Acta. 1862: 105-12. PMID 26542217 DOI: 10.1016/j.bbadis.2015.10.027  0.48
2016 Droogsma E, van Asselt D, van Steijn J, Diekhuis M, Veeger N, De Deyn PP. Long-term Course of Alzheimer Disease in Patients Treated According to the Dutch Dementia Guideline at a Memory Clinic: A "Real-Life" Study. Alzheimer Disease and Associated Disorders. 30: 53-9. PMID 25756604 DOI: 10.1097/WAD.0000000000000090  0.52
2016 Niemantsverdriet E, Goossens J, Struyfs H, Martin JJ, Goeman J, De Deyn PP, Vanderstichele H, Engelborghs S. Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease Journal of Alzheimer's Disease. 51: 97-106. DOI: 10.3233/JAD-150953  0.52
2016 Van Dam D, Vermeiren Y, Dekker AD, Naudé PJW, De Deyn PP. Neuropsychiatric disturbances in Alzheimer’s disease: What have we learned from neuropathological studies? Current Alzheimer Research. 13: 1145-1164. DOI: 10.2174/1567205013666160502123607  0.52
2016 Van Der Vorst A, Zijlstra GAR, De Witte N, Duppen D, Stuck AE, Kempen GIJM, Schols JMGA, De Deyn PP, De Donder L, De Lepeleire J, De Roeck E, Dierckxc E, Dury S, Engelborghs S, Fret B, et al. Limitations in activities of daily living in community-dwelling people aged 75 and over: A systematic literature review of risk and protective factors Plos One. 11. DOI: 10.1371/journal.pone.0165127  0.52
2016 De Coninck M, Van Hecke W, Crols R, van Dun K, Van Dam D, De Deyn PP, Brysbaert M, Mariën P. Cerebral and cerebellar language organization in a right-handed subject with a left temporal porencephalic cyst: An fMRI study Journal of Neurolinguistics. 37: 41-46. DOI: 10.1016/j.jneuroling.2015.08.004  0.52
2015 Van Mossevelde S, van der Zee J, Gijselinck I, Engelborghs S, Sieben A, Van Langenhove T, De Bleecker J, Baets J, Vandenbulcke M, Van Laere K, Ceyssens S, Van den Broeck M, Peeters K, Mattheijssens M, Cras P, ... ... De Deyn PP, et al. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort. Brain : a Journal of Neurology. PMID 26674655 DOI: 10.1093/brain/awv358  0.52
2015 Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Philtjens S, Heeman B, Engelborghs S, Vandenbulcke M, De Baets G, Bäumer V, Cuijt I, Van den Broeck M, Peeters K, Mattheijssens M, Rousseau F, ... ... De Deyn PP, et al. Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology. PMID 26581300 DOI: 10.1212/WNL.0000000000002220  0.52
2015 Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Engelborghs S, De Bleecker J, Ivanoiu A, Deryck O, Edbauer D, Zhang M, Heeman B, Bäumer V, Van den Broeck M, Mattheijssens M, Peeters K, ... ... de Deyn PP, et al. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Molecular Psychiatry. PMID 26481318 DOI: 10.1038/mp.2015.159  0.52
2015 Wostyn P, De Groot V, Van Dam D, Audenaert K, Killer HE, De Deyn PP. Glaucoma and the Role of Cerebrospinal Fluid Dynamics. Investigative Ophthalmology & Visual Science. 56: 6630-1. PMID 26465892 DOI: 10.1167/iovs.15-18016  0.48
2015 Cacace R, Van den Bossche T, Engelborghs S, Geerts N, Laureys A, Dillen L, Graff C, Thonberg H, Chiang HH, Pastor P, Ortega-Cubero S, Pastor MA, Diehl-Schmid J, Alexopoulos P, Benussi L, ... ... De Deyn PP, et al. Rare Variants in PLD3 do not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort. Human Mutation. PMID 26411346 DOI: 10.1002/humu.22908  0.52
2015 Amhaoul H, Hamaide J, Bertoglio D, Reichel SN, Verhaeghe J, Geerts E, Van Dam D, De Deyn PP, Kumar-Singh S, Katsifis A, Van Der Linden A, Staelens S, Dedeurwaerdere S. Brain inflammation in a chronic epilepsy model: Evolving pattern of the translocator protein during epileptogenesis. Neurobiology of Disease. 82: 526-39. PMID 26388398 DOI: 10.1016/j.nbd.2015.09.004  0.48
2015 Dekker AD, Strydom A, Coppus AM, Nizetic D, Vermeiren Y, Naudé PJ, Van Dam D, Potier MC, Fortea J, De Deyn PP. Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease? Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 73: 36-61. PMID 26343344 DOI: 10.1016/j.cortex.2015.07.032  0.52
2015 Thienpont L, Verhofstadt M, Van Loon T, Distelmans W, Audenaert K, De Deyn PP. Euthanasia requests, procedures and outcomes for 100 Belgian patients suffering from psychiatric disorders: a retrospective, descriptive study. Bmj Open. 5: e007454. PMID 26216150 DOI: 10.1136/bmjopen-2014-007454  0.52
2015 Bettens K, Vermeulen S, Van Cauwenberghe C, Heeman B, Asselbergh B, Robberecht C, Engelborghs S, Vandenbulcke M, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, Sleegers K. Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations. Molecular Neurodegeneration. 10: 30. PMID 26179372 DOI: 10.1186/s13024-015-0024-9  0.52
2015 Janssen L, Sobott F, De Deyn PP, Van Dam D. Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method. Methodsx. 2: 112-23. PMID 26150979 DOI: 10.1016/j.mex.2015.02.011  0.52
2015 Cuyvers E, De Roeck A, Van den Bossche T, Van Cauwenberghe C, Bettens K, Vermeulen S, Mattheijssens M, Peeters K, Engelborghs S, Vandenbulcke M, Vandenberghe R, De Deyn PP, Van Broeckhoven C, Sleegers K. Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study. The Lancet. Neurology. 14: 814-22. PMID 26141617 DOI: 10.1016/S1474-4422(15)00133-7  0.52
2015 Struyfs H, Niemantsverdriet E, Goossens J, Fransen E, Martin JJ, De Deyn PP, Engelborghs S. Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis. Frontiers in Neurology. 6: 138. PMID 26136723 DOI: 10.3389/fneur.2015.00138  0.52
2015 Wostyn P, Van Dam D, Audenaert K, Killer HE, De Deyn PP, De Groot V. A new glaucoma hypothesis: a role of glymphatic system dysfunction. Fluids and Barriers of the Cns. 12: 16. PMID 26118970 DOI: 10.1186/s12987-015-0012-z  0.52
2015 Sleegers K, Bettens K, De Roeck A, Van Cauwenberghe C, Cuyvers E, Verheijen J, Struyfs H, Van Dongen J, Vermeulen S, Engelborghs S, Vandenbulcke M, Vandenberghe R, De Deyn PP, Van Broeckhoven C. A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 1452-60. PMID 26086184 DOI: 10.1016/j.jalz.2015.02.013  0.52
2015 Verreet T, Quintens R, Van Dam D, Verslegers M, Tanori M, Casciati A, Neefs M, Leysen L, Michaux A, Janssen A, D'Agostino E, Vande Velde G, Baatout S, Moons L, Pazzaglia S, ... ... De Deyn PP, et al. A multidisciplinary approach unravels early and persistent effects of X-ray exposure at the onset of prenatal neurogenesis. Journal of Neurodevelopmental Disorders. 7: 3. PMID 26029273 DOI: 10.1186/1866-1955-7-3  0.52
2015 Droogsma E, van Asselt D, De Deyn PP. Weight loss and undernutrition in community-dwelling patients with Alzheimer's dementia: From population based studies to clinical management. Zeitschrift FüR Gerontologie Und Geriatrie. 48: 318-24. PMID 25990006 DOI: 10.1007/s00391-015-0891-2  0.52
2015 Le Bastard N, De Deyn PP, Engelborghs S. Importance and impact of preanalytical variables on Alzheimer disease biomarker concentrations in cerebrospinal fluid. Clinical Chemistry. 61: 734-43. PMID 25869575 DOI: 10.1373/clinchem.2014.236679  0.52
2015 Droogsma E, van Asselt D, Bieze H, Veeger N, De Deyn PP. The relationship of weight change trajectory with medial temporal lobe atrophy in patients with mild Alzheimer's disease: results from a cohort study. Alzheimer's Research & Therapy. 7: 18. PMID 25848400 DOI: 10.1186/s13195-015-0098-1  0.52
2015 Cuyvers E, van der Zee J, Bettens K, Engelborghs S, Vandenbulcke M, Robberecht C, Dillen L, Merlin C, Geerts N, Graff C, Thonberg H, Chiang HH, Pastor P, Ortega-Cubero S, Pastor MA, ... ... De Deyn PP, et al. Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study. Neurobiology of Aging. 36: 2005.e15-22. PMID 25796131 DOI: 10.1016/j.neurobiolaging.2015.02.014  0.52
2015 Braat S, D'Hulst C, Heulens I, De Rubeis S, Mientjes E, Nelson DL, Willemsen R, Bagni C, Van Dam D, De Deyn PP, Kooy RF. The GABAA Receptor is an FMRP Target with Therapeutic Potential in Fragile X Syndrome. Cell Cycle (Georgetown, Tex.). 0. PMID 25790165 DOI: 10.4161/15384101.2014.989114  0.48
2015 Droogsma E, van Asselt D, Diekhuis M, Veeger N, van der Hooft C, De Deyn PP. Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer's disease. International Psychogeriatrics / Ipa. 27: 1323-33. PMID 25779465 DOI: 10.1017/S1041610215000289  0.52
2015 Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, Martin JJ, De Deyn PP. The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease. Alzheimer's Research & Therapy. 7: 7. PMID 25717350 DOI: 10.1186/s13195-014-0090-1  0.52
2015 Niemantsverdriet E, Feyen BF, Le Bastard N, Martin JJ, Goeman J, De Deyn PP, Engelborghs S. Overdiagnosing Vascular Dementia using Structural Brain Imaging for Dementia Work-Up. Journal of Alzheimer's Disease : Jad. 45: 1039-43. PMID 25633672 DOI: 10.3233/JAD-142103  0.52
2015 Struyfs H, Van Broeck B, Timmers M, Fransen E, Sleegers K, Van Broeckhoven C, De Deyn PP, Streffer JR, Mercken M, Engelborghs S. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis. Journal of Alzheimer's Disease : Jad. 45: 813-22. PMID 25633670 DOI: 10.3233/JAD-141986  0.52
2015 Naudé PJ, Dekker AD, Coppus AM, Vermeiren Y, Eisel UL, van Duijn CM, Van Dam D, De Deyn PP. Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome. Journal of Alzheimer's Disease : Jad. 45: 733-43. PMID 25613101 DOI: 10.3233/JAD-142514  0.52
2015 Shah D, Blockx I, Guns PJ, De Deyn PP, Van Dam D, Jonckers E, Delgado Y Palacios R, Verhoye M, Van der Linden A. Acute modulation of the cholinergic system in the mouse brain detected by pharmacological resting-state functional MRI. Neuroimage. 109: 151-9. PMID 25583611 DOI: 10.1016/j.neuroimage.2015.01.009  0.52
2015 Dorey A, Tholance Y, Vighetto A, Perret-Liaudet A, Lachman I, Krolak-Salmon P, Wagner U, Struyfs H, De Deyn PP, El-Moualij B, Zorzi W, Meyronet D, Streichenberger N, Engelborghs S, Kovacs GG, et al. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease. Jama Neurology. 72: 267-75. PMID 25559883 DOI: 10.1001/jamaneurol.2014.4068  0.52
2015 Roth L, Van Dam D, Van der Donckt C, Schrijvers DM, Lemmens K, Van Brussel I, De Deyn PP, Martinet W, De Meyer GR. Impaired gait pattern as a sensitive tool to assess hypoxic brain damage in a novel mouse model of atherosclerotic plaque rupture. Physiology & Behavior. 139: 397-402. PMID 25449385 DOI: 10.1016/j.physbeh.2014.11.047  0.52
2015 Kehoe K, Brouns R, Verkerk R, Engelborghs S, De Deyn PP, Hendriks D, De Meester I. Prolyl carboxypeptidase activity decline correlates with severity and short-term outcome in acute ischemic stroke. Neurochemical Research. 40: 81-8. PMID 25370794 DOI: 10.1007/s11064-014-1468-y  0.52
2015 Slaets S, Van Acker F, Versijpt J, Hauth L, Goeman J, Martin JJ, De Deyn PP, Engelborghs S. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis. International Journal of Geriatric Psychiatry. 30: 864-9. PMID 25363642 DOI: 10.1002/gps.4229  0.52
2015 Van der Mussele S, Mariën P, Saerens J, Somers N, Goeman J, De Deyn PP, Engelborghs S. Psychosis associated behavioral and psychological signs and symptoms in mild cognitive impairment and Alzheimer's dementia. Aging & Mental Health. 19: 818-28. PMID 25323000 DOI: 10.1080/13607863.2014.967170  0.52
2015 Dekker AD, Coppus AM, Vermeiren Y, Aerts T, van Duijn CM, Kremer BP, Naudé PJ, Van Dam D, De Deyn PP. Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome. Journal of Alzheimer's Disease : Jad. 43: 871-91. PMID 25125467 DOI: 10.3233/JAD-140783  0.52
2015 Van der Mussele S, Le Bastard N, Saerens J, Somers N, Mariën P, Goeman J, De Deyn PP, Engelborghs S. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia. Aging & Mental Health. 19: 247-57. PMID 24962058 DOI: 10.1080/13607863.2014.924900  0.52
2015 Wostyn P, De Groot V, Van Dam D, Audenaert K, De Deyn PP. Intracranial pressure fluctuations: a potential risk factor for glaucoma? Acta Ophthalmologica. 93: e83-4. PMID 24373563 DOI: 10.1111/aos.12331  0.52
2015 Toledo JB, Zetterberg H, Van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, ... ... De Deyn PP, et al. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects Brain. 138: 2701-2715. DOI: 10.1093/brain/awv199  0.52
2014 Aalten P, Ramakers IH, Biessels GJ, de Deyn PP, Koek HL, OldeRikkert MG, Oleksik AM, Richard E, Smits LL, van Swieten JC, Teune LK, van der Lugt A, Barkhof F, Teunissen CE, Rozendaal N, et al. The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results. Bmc Neurology. 14: 254. PMID 25551191 DOI: 10.1186/s12883-014-0254-4  0.52
2014 De Ryck A, Fransen E, Brouns R, Geurden M, Peij D, Mariën P, De Deyn PP, Engelborghs S. Poststroke depression and its multifactorial nature: results from a prospective longitudinal study. Journal of the Neurological Sciences. 347: 159-66. PMID 25451004 DOI: 10.1016/j.jns.2014.09.038  0.52
2014 Sheorajpanday RV, Mariën P, Nagels G, Weeren AJ, Saerens J, van Putten MJ, De Deyn PP. Subcortical vascular cognitive impairment, no dementia: EEG global power independently predicts vascular impairment and brain symmetry index reflects severity of cognitive decline. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. 31: 422-8. PMID 25271680 DOI: 10.1097/WNP.0000000000000060  0.52
2014 Van Hooff RJ, Nieboer K, De Smedt A, Moens M, De Deyn PP, De Keyser J, Brouns R. Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke. Clinical Neurology and Neurosurgery. 125: 189-93. PMID 25171393 DOI: 10.1016/j.clineuro.2014.08.011  0.52
2014 Wostyn P, De Groot V, Van Dam D, Audenaert K, Killer HE, De Deyn PP. Glaucoma considered as an imbalance between production and clearance of neurotoxins. Investigative Ophthalmology & Visual Science. 55: 5351-2. PMID 25159589 DOI: 10.1167/iovs.14-15041  0.52
2014 de Bock L, Somers K, Fraussen J, Hendriks JJ, van Horssen J, Rouwette M, Hellings N, Villar LM, Alvarez-Cermeño JC, Espiño M, Hupperts R, Jongen P, Damoiseaux J, Verbeek MM, De Deyn PP, et al. Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 193: 2147-56. PMID 25086173 DOI: 10.4049/jimmunol.1401166  0.52
2014 Van der Mussele S, Fransen E, Struyfs H, Luyckx J, Mariën P, Saerens J, Somers N, Goeman J, De Deyn PP, Engelborghs S. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study. Journal of Alzheimer's Disease : Jad. 42: 1239-50. PMID 25024328 DOI: 10.3233/JAD-140405  0.52
2014 Naudé PJ, den Boer JA, Comijs HC, Bosker FJ, Zuidersma M, Groenewold NA, De Deyn PP, Luiten PG, Eisel UL, Oude Voshaar RC. Sex-specific associations between Neutrophil Gelatinase-Associated Lipocalin (NGAL) and cognitive domains in late-life depression. Psychoneuroendocrinology. 48: 169-77. PMID 25019974 DOI: 10.1016/j.psyneuen.2014.06.016  0.52
2014 Gielen J, Laton J, Van Schependom J, De Deyn PP, Nagels G. The squares test as a measure of hand function in multiple sclerosis. Clinical Neurology and Neurosurgery. 123: 55-60. PMID 25012012 DOI: 10.1016/j.clineuro.2014.05.008  0.52
2014 Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, De Deyn PP. Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease. Neurobiology of Aging. 35: 2691-700. PMID 24997673 DOI: 10.1016/j.neurobiolaging.2014.05.031  0.52
2014 Dekker AD, De Deyn PP, Rots MG. Epigenetics: the neglected key to minimize learning and memory deficits in Down syndrome. Neuroscience and Biobehavioral Reviews. 45: 72-84. PMID 24858130 DOI: 10.1016/j.neubiorev.2014.05.004  0.52
2014 Van Dam D, Vermeiren Y, Aerts T, De Deyn PP. Novel and sensitive reversed-phase high-pressure liquid chromatography method with electrochemical detection for the simultaneous and fast determination of eight biogenic amines and metabolites in human brain tissue. Journal of Chromatography. A. 1353: 28-39. PMID 24857034 DOI: 10.1016/j.chroma.2014.05.004  0.52
2014 Droogsma E, van Asselt D, van Steijn J, Veeger N, van Dusseldorp I, De Deyn PP. Nutritional interventions in community-dwelling Alzheimer patients with (risk of) undernutrition: a systematic review. International Psychogeriatrics / Ipa. 1-9. PMID 24846712 DOI: 10.1017/S1041610214000817  0.52
2014 De Ryck A, Brouns R, Geurden M, Elseviers M, De Deyn PP, Engelborghs S. Risk factors for poststroke depression: identification of inconsistencies based on a systematic review. Journal of Geriatric Psychiatry and Neurology. 27: 147-58. PMID 24713406 DOI: 10.1177/0891988714527514  0.52
2014 Struyfs H, Molinuevo JL, Martin JJ, De Deyn PP, Engelborghs S. Validation of the AD-CSF-index in autopsy-confirmed Alzheimer's disease patients and healthy controls. Journal of Alzheimer's Disease : Jad. 41: 903-9. PMID 24705548 DOI: 10.3233/JAD-131085  0.52
2014 Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, De Deyn PP. Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 41: 819-33. PMID 24685637 DOI: 10.3233/JAD-140309  0.52
2014 Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, ... ... De Deyn PP, et al. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathologica. 127: 407-18. PMID 24442578 DOI: 10.1007/s00401-013-1239-x  0.52
2014 Slaets S, Vanmechelen E, Le Bastard N, Decraemer H, Vandijck M, Martin JJ, De Deyn PP, Engelborghs S. Increased CSF α-synuclein levels in Alzheimer's disease: correlation with tau levels. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S290-8. PMID 24439167 DOI: 10.1016/j.jalz.2013.10.004  0.52
2014 Emre M, Poewe W, De Deyn PP, Barone P, Kulisevsky J, Pourcher E, van Laar T, Storch A, Micheli F, Burn D, Durif F, Pahwa R, Callegari F, Tenenbaum N, Strohmaier C. Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study. Clinical Neuropharmacology. 37: 9-16. PMID 24434526 DOI: 10.1097/WNF.0000000000000010  0.52
2014 Gebruers N, Truijen S, Engelborghs S, De Deyn PP. Prediction of upper limb recovery, general disability, and rehabilitation status by activity measurements assessed by accelerometers or the Fugl-Meyer score in acute stroke. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 93: 245-52. PMID 24398579 DOI: 10.1097/PHM.0000000000000045  0.52
2014 Wostyn P, De Groot V, Van Dam D, Audenaert K, De Deyn PP. The role of low intracranial pressure in the development of glaucoma in patients with Alzheimer's disease. Progress in Retinal and Eye Research. 39: 107-8. PMID 24393666 DOI: 10.1016/j.preteyeres.2013.12.002  0.52
2014 van Velzen MH, Nanetti L, de Deyn PP. Data modelling in corpus linguistics: how low may we go? Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 55: 192-201. PMID 24332294 DOI: 10.1016/j.cortex.2013.10.010  0.52
2014 Cuyvers E, Bettens K, Philtjens S, Van Langenhove T, Gijselinck I, van der Zee J, Engelborghs S, Vandenbulcke M, Van Dongen J, Geerts N, Maes G, Mattheijssens M, Peeters K, Cras P, Vandenberghe R, ... De Deyn PP, et al. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Neurobiology of Aging. 35: 726.e11-9. PMID 24119542 DOI: 10.1016/j.neurobiolaging.2013.09.009  0.52
2014 Van der Mussele S, Mariën P, Saerens J, Somers N, Goeman J, De Deyn PP, Engelborghs S. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 38: 319-29. PMID 23963290 DOI: 10.3233/JAD-130596  0.52
2014 De Ryck A, Fransen E, Brouns R, Geurden M, Peij D, Mariën P, De Deyn PP, Engelborghs S. Psychosocial problems associated with depression at 18 months poststroke. International Journal of Geriatric Psychiatry. 29: 144-52. PMID 23625635 DOI: 10.1002/gps.3974  0.52
2014 Decaluwé R, Maes D, Cools A, Wuyts B, De Smet S, Marescau B, De Deyn PP, Janssens GPJ. Effect of peripartal feeding strategy on colostrum yield and composition in sows Journal of Animal Science. 92: 3557-3567. DOI: 10.2527/jas2014-7612  0.52
2014 Reesink FE, Stormezand GN, De Deyn PP, Dierckx RAJO. Nuclear imaging in frontotemporal dementia Pet and Spect in Neurology. 339-357. DOI: 10.1007/978-3-642-54307-4_15  0.52
2014 Van Dam D, De Deyn PP. Animal models for brain research Pet and Spect of Neurobiological Systems. 3-46. DOI: 10.1007/978-3-642-42014-6_1  0.52
2014 Vieira TS, Voshaar RO, de Deyn PP, Dierckx RAJO, van Waarde A. SPECT and PET in late-life depression Pet and Spect in Psychiatry. 185-208. DOI: 10.1007/978-3-642-40384-2_7  0.52
2014 Vermeiren Y, van Dam D, de Deyn PP. Psychiatric disorders in dementia Pet and Spect in Psychiatry. 271-324. DOI: 10.1007/978-3-642-40384-2_11  0.52
2013 Gebruers N, Truijen S, Engelborghs S, De Deyn PP. Predictive value of upper-limb accelerometry in acute stroke with hemiparesis. Journal of Rehabilitation Research and Development. 50: 1099-106. PMID 24458895 DOI: 10.1682/JRRD.2012.09.0166  0.52
2013 Banzhaf-Strathmann J, Claus R, Mücke O, Rentzsch K, van der Zee J, Engelborghs S, De Deyn PP, Cruts M, van Broeckhoven C, Plass C, Edbauer D. Promoter DNA methylation regulates progranulin expression and is altered in FTLD. Acta Neuropathologica Communications. 1: 16. PMID 24252647 DOI: 10.1186/2051-5960-1-16  0.52
2013 Naudé PJ, Eisel UL, Comijs HC, Groenewold NA, De Deyn PP, Bosker FJ, Luiten PG, den Boer JA, Oude Voshaar RC. Neutrophil gelatinase-associated lipocalin: a novel inflammatory marker associated with late-life depression. Journal of Psychosomatic Research. 75: 444-50. PMID 24182633 DOI: 10.1016/j.jpsychores.2013.08.023  0.52
2013 Choe CU, Atzler D, Wild PS, Carter AM, Böger RH, Ojeda F, Simova O, Stockebrand M, Lackner K, Nabuurs C, Marescau B, Streichert T, Müller C, Lüneburg N, De Deyn PP, et al. Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation. 128: 1451-61. PMID 24004504 DOI: 10.1161/CIRCULATIONAHA.112.000580  0.52
2013 Kasten J, Hu C, Bhargava R, Park H, Tai D, Byrne JA, Marescau B, De Deyn PP, Schlichting L, Grody WW, Cederbaum SD, Lipshutz GS. Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse. Molecular Genetics and Metabolism. 110: 222-30. PMID 23920045 DOI: 10.1016/j.ymgme.2013.06.020  0.52
2013 Rouwette M, Noben JP, Van Horssen J, Van Wijmeersch B, Hupperts R, Jongen PJ, Verbeek MM, De Deyn PP, Stinissen P, Somers V. Identification of coronin-1a as a novel antibody target for clinically isolated syndrome and multiple sclerosis. Journal of Neurochemistry. 126: 483-92. PMID 23745754 DOI: 10.1111/jnc.12335  0.52
2013 Slaets S, Le Bastard N, Martin JJ, Sleegers K, Van Broeckhoven C, De Deyn PP, Engelborghs S. Cerebrospinal fluid Aβ1-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels. Journal of Alzheimer's Disease : Jad. 36: 759-67. PMID 23666174 DOI: 10.3233/JAD-130107  0.52
2013 Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, Boada M, Bullock R, De Deyn PP, Frisoni GB, Hampel H, Jones RW, Kehoe P, Lenoir H, Minthon L, et al. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study. Dementia and Geriatric Cognitive Disorders. 36: 1-19. PMID 23651945 DOI: 10.1159/000348354  0.52
2013 Van Dam D, Van Dijck A, Janssen L, De Deyn PP. Neuropeptides in Alzheimer's disease: from pathophysiological mechanisms to therapeutic opportunities. Current Alzheimer Research. 10: 449-68. PMID 23627705 DOI: 10.2174/1567205011310050001  0.52
2013 Van Leuven W, Van Dam D, Moens L, De Deyn PP, Dewilde S. A behavioural study of neuroglobin-overexpressing mice under normoxic and hypoxic conditions. Biochimica Et Biophysica Acta. 1834: 1764-71. PMID 23612353 DOI: 10.1016/j.bbapap.2013.04.015  0.52
2013 Wostyn P, De Groot V, Van Dam D, Audenaert K, De Deyn PP. Senescent changes in cerebrospinal fluid circulatory physiology and their role in the pathogenesis of normal-tension glaucoma. American Journal of Ophthalmology. 156: 5-14.e2. PMID 23608683 DOI: 10.1016/j.ajo.2013.03.003  0.52
2013 Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. Jama Neurology. 70: 727-35. PMID 23588557 DOI: 10.1001/jamaneurol.2013.1925  0.52
2013 Van Cauwenberghe C, Bettens K, Engelborghs S, Vandenbulcke M, Van Dongen J, Vermeulen S, Vandenberghe R, De Deyn PP, Van Broeckhoven C, Sleegers K. Complement receptor 1 coding variant p.Ser1610Thr in Alzheimer's disease and related endophenotypes. Neurobiology of Aging. 34: 2235.e1-6. PMID 23582656 DOI: 10.1016/j.neurobiolaging.2013.03.008  0.52
2013 Sheorajpanday RV, Marien P, Weeren AJ, Nagels G, Saerens J, van Putten MJ, De Deyn PP. EEG in silent small vessel disease: sLORETA mapping reveals cortical sources of vascular cognitive impairment no dementia in the default mode network. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. 30: 178-87. PMID 23545769 DOI: 10.1097/WNP.0b013e3182767d15  0.52
2013 Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, Geller F, Sottejeau Y, Harold D, Dourlen P, Grenier-Boley B, Kamatani Y, Delepine B, Demiautte F, Zelenika D, ... ... De Deyn PP, et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Molecular Psychiatry. 18: 1225-34. PMID 23399914 DOI: 10.1038/mp.2013.1  0.52
2013 Cacace R, Van Cauwenberghe C, Bettens K, Gijselinck I, van der Zee J, Engelborghs S, Vandenbulcke M, Van Dongen J, Bäumer V, Dillen L, Mattheijssens M, Peeters K, Cruts M, Vandenberghe R, De Deyn PP, et al. C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging. 34: 1712.e1-7. PMID 23352322 DOI: 10.1016/j.neurobiolaging.2012.12.019  0.52
2013 De Deyn PP, Drenth AF, Kremer BP, Oude Voshaar RC, Van Dam D. Aripiprazole in the treatment of Alzheimer's disease. Expert Opinion On Pharmacotherapy. 14: 459-74. PMID 23350964 DOI: 10.1517/14656566.2013.764989  0.52
2013 Van Langenhove T, van der Zee J, Gijselinck I, Engelborghs S, Vandenberghe R, Vandenbulcke M, De Bleecker J, Sieben A, Versijpt J, Ivanoiu A, Deryck O, Willems C, Dillen L, Philtjens S, Maes G, ... ... De Deyn PP, et al. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. Jama Neurology. 70: 365-73. PMID 23338682 DOI: 10.1001/2013.jamaneurol.181  0.52
2013 Engelborghs S, Sleegers K, Van der Mussele S, Le Bastard N, Brouwers N, Van Broeckhoven C, De Deyn PP. Brain-specific tryptophan hydroxylase, TPH2, and 5-HTTLPR are associated with frontal lobe symptoms in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 35: 67-73. PMID 23334703 DOI: 10.3233/JAD-101305  0.52
2013 Dillen L, Van Langenhove T, Engelborghs S, Vandenbulcke M, Sarafov S, Tournev I, Merlin C, Cras P, Vandenberghe R, De Deyn PP, Jordanova A, Cruts M, Van Broeckhoven C, van der Zee J. Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients. Neurobiology of Aging. 34: 1711.e1-5. PMID 23312802 DOI: 10.1016/j.neurobiolaging.2012.12.007  0.52
2013 Van der Mussele S, Bekelaar K, Le Bastard N, Vermeiren Y, Saerens J, Somers N, Mariën P, Goeman J, De Deyn PP, Engelborghs S. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease. International Journal of Geriatric Psychiatry. 28: 947-58. PMID 23255479 DOI: 10.1002/gps.3909  0.52
2013 De Brabander I, Yperzeele L, Ceuterick-De Groote C, Brouns R, Baker R, Belachew S, Delbecq J, De Keulenaer G, Dethy S, Eyskens F, Fumal A, Hemelsoet D, Hughes D, Jeangette S, Nuytten D, ... ... De Deyn PP, et al. Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young. Clinical Neurology and Neurosurgery. 115: 1088-93. PMID 23219219 DOI: 10.1016/j.clineuro.2012.11.003  0.52
2013 Vermeiren Y, Le Bastard N, Van Hemelrijck A, Drinkenburg WH, Engelborghs S, De Deyn PP. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 488-98. PMID 23159046 DOI: 10.1016/j.jalz.2012.06.010  0.52
2013 van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Engelborghs S, Philtjens S, Vandenbulcke M, Sleegers K, Sieben A, Bäumer V, Maes G, Corsmit E, Borroni B, Padovani A, ... ... De Deyn PP, ... ... De Deyn PP, ... ... De Deyn PP, et al. A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Human Mutation. 34: 363-73. PMID 23111906 DOI: 10.1002/humu.22244  0.52
2013 Mariën P, Vidts A, Van Hecke W, De Surgeloose D, De Belder F, Parizel PM, Engelborghs S, De Deyn PP, Verhoeven J. Mastication dyspraxia: a neurodevelopmental disorder reflecting disruption of the cerebellocerebral network involved in planned actions. Cerebellum (London, England). 12: 277-89. PMID 23065651 DOI: 10.1007/s12311-012-0420-4  0.52
2013 Le Bastard N, Aerts L, Sleegers K, Martin JJ, Van Broeckhoven C, De Deyn PP, Engelborghs S. Longitudinal stability of cerebrospinal fluid biomarker levels: fulfilled requirement for pharmacodynamic markers in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 33: 807-22. PMID 23034521 DOI: 10.3233/JAD-2012-110029  0.52
2013 Van der Mussele S, Le Bastard N, Vermeiren Y, Saerens J, Somers N, Mariën P, Goeman J, De Deyn PP, Engelborghs S. Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults. International Journal of Geriatric Psychiatry. 28: 265-75. PMID 22549770 DOI: 10.1002/gps.3820  0.52
2013 Mets T, De Deyn PP, Pals P, De Lepeleire J, Vandewoude M, Ventura M, Ivanoiu A, Albert A, Seghers AK. COGNOS: care for people with cognitive dysfunction: a national observational study. Alzheimer Disease and Associated Disorders. 27: 123-32. PMID 22546783 DOI: 10.1097/WAD.0b013e318256d1d0  0.52
2013 Mariën P, De Smet HJ, Wijgerde E, Verhoeven J, Crols R, De Deyn PP. Posterior fossa syndrome in adults: a new case and comprehensive survey of the literature. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 49: 284-300. PMID 21855865 DOI: 10.1016/j.cortex.2011.06.018  0.52
2012 Leker RR, Molina C, Cockroft K, Liebeskind DS, Concha M, Shuaib A, De Deyn PP, Burgin WS, Gupta R, Dillon W, Diener HC. Effects of age on outcome in the SENTIS trial: better outcomes in elderly patients. Cerebrovascular Diseases (Basel, Switzerland). 34: 263-71. PMID 23075518 DOI: 10.1159/000342668  0.52
2012 Theuns J, Crosiers D, Debaene L, Nuytemans K, Meeus B, Sleegers K, Goossens D, Corsmit E, Elinck E, Peeters K, Mattheijssens M, Pickut B, Del-Favero J, Engelborghs S, De Deyn PP, et al. Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa-responsive dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1451-6. PMID 22976901 DOI: 10.1002/mds.25147  0.52
2012 Rouwette M, Somers K, Govarts C, De Deyn PP, Hupperts R, Van Wijmeersch B, De Jong BA, Verbeek MM, Van Pesch V, Sindic C, Villar LM, Álvarez-Cermeño JC, Stinissen P, Somers V. Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome. Journal of Neurochemistry. 123: 568-77. PMID 22958230 DOI: 10.1111/jnc.12005  0.52
2012 Sieben A, Van Langenhove T, Engelborghs S, Martin JJ, Boon P, Cras P, De Deyn PP, Santens P, Van Broeckhoven C, Cruts M. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathologica. 124: 353-72. PMID 22890575 DOI: 10.1007/s00401-012-1029-x  0.52
2012 Wils H, Kleinberger G, Pereson S, Janssens J, Capell A, Van Dam D, Cuijt I, Joris G, De Deyn PP, Haass C, Van Broeckhoven C, Kumar-Singh S. Cellular ageing, increased mortality and FTLD-TDP-associated neuropathology in progranulin knockout mice. The Journal of Pathology. 228: 67-76. PMID 22733568 DOI: 10.1002/path.4043  0.52
2012 Naudé PJ, Nyakas C, Eiden LE, Ait-Ali D, van der Heide R, Engelborghs S, Luiten PG, De Deyn PP, den Boer JA, Eisel UL. Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2811-23. PMID 22441986 DOI: 10.1096/fj.11-202457  0.52
2012 Verstraeten A, Wauters E, Crosiers D, Meeus B, Corsmit E, Elinck E, Mattheijssens M, Peeters K, Cras P, Pickut B, Vandenberghe R, Engelborghs S, De Deyn PP, Van Broeckhoven C, Theuns J. Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population. Neurobiology of Aging. 33: 1844.e11-3. PMID 22336192 DOI: 10.1016/j.neurobiolaging.2012.01.006  0.52
2012 Heulens I, D'Hulst C, Van Dam D, De Deyn PP, Kooy RF. Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model. Behavioural Brain Research. 229: 244-9. PMID 22285772 DOI: 10.1016/j.bbr.2012.01.031  0.52
2012 Bettens K, Brouwers N, Engelborghs S, Lambert JC, Rogaeva E, Vandenberghe R, Le Bastard N, Pasquier F, Vermeulen S, Van Dongen J, Mattheijssens M, Peeters K, Mayeux R, St George-Hyslop P, Amouyel P, ... De Deyn PP, et al. Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk. Molecular Neurodegeneration. 7: 3. PMID 22248099 DOI: 10.1186/1750-1326-7-3  0.52
2012 Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S, Engelborghs S, Sieben A, De Jonghe P, Vandenberghe R, Santens P, ... ... De Deyn PP, et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. The Lancet. Neurology. 11: 54-65. PMID 22154785 DOI: 10.1016/S1474-4422(11)70261-7  0.52
2012 Meeus B, Verstraeten A, Crosiers D, Engelborghs S, Van den Broeck M, Mattheijssens M, Peeters K, Corsmit E, Elinck E, Pickut B, Vandenberghe R, Cras P, De Deyn PP, Van Broeckhoven C, Theuns J. DLB and PDD: a role for mutations in dementia and Parkinson disease genes? Neurobiology of Aging. 33: 629.e5-629.e18. PMID 22118943 DOI: 10.1016/j.neurobiolaging.2011.10.014  0.52
2012 Van Langenhove T, van der Zee J, Engelborghs S, Vandenberghe R, Santens P, Van den Broeck M, Mattheijssens M, Peeters K, Nuytten D, Cras P, De Deyn PP, De Jonghe P, Cruts M, Van Broeckhoven C. Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts. Neurobiology of Aging. 33: 1004.e17-20. PMID 22035589 DOI: 10.1016/j.neurobiolaging.2011.09.025  0.52
2012 Mariën P, Tops W, Crols R, Jonkers R, De Deyn PP, Verhoeven J. Grammar disruption in a patient with Neuro-Sweet syndrome. Neurocase. 18: 235-47. PMID 21879995 DOI: 10.1080/13554794.2011.588178  0.52
2012 De Deyn PP, Eriksson H, Svensson H. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study. International Journal of Geriatric Psychiatry. 27: 296-304. PMID 21538537 DOI: 10.1002/gps.2720  0.52
2012 Brouwers N, Van Cauwenberghe C, Engelborghs S, Lambert JC, Bettens K, Le Bastard N, Pasquier F, Montoya AG, Peeters K, Mattheijssens M, Vandenberghe R, Deyn PP, Cruts M, Amouyel P, Sleegers K, et al. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Molecular Psychiatry. 17: 223-33. PMID 21403675 DOI: 10.1038/mp.2011.24  0.52
2012 Sprigg N, Gray LJ, Bath PM, Christensen H, De Deyn PP, Leys D, O'Neill D, Ringelstein EB. Quality of life after ischemic stroke varies in western countries: data from the tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 21: 587-93. PMID 21388828 DOI: 10.1016/j.jstrokecerebrovasdis.2011.01.007  0.52
2012 Glaudemans AWJM, Dierckx RAJO, Otte A, Kusić Z, Pruim J, De Deyn PP. Good clinical practice and nuclear medicine Trends On the Role of Pet in Drug Development. 691-725. DOI: 10.1142/9789814317740_0025  0.52
2012 Eloot S, Glorieux G, De Deyn PP, Vanholder R. Guanidino Compounds Uremic Toxins. 125-142. DOI: 10.1002/9781118424032.ch9  0.52
2012 Crosiers D, Pickut B, Theuns J, De Deyn PP, Van Broeckhoven C, Martinez-Martin P, Ray Chaudhuri K, Cras P. Non-motor symptoms in a Flanders-Belgian population of 215 Parkinson’s disease patients as assessed by the non-motor symptoms questionnaire American Journal of Neurodegenerative Diseases. 1: 160-167.  0.52
2011 Hermans E, Mariën P, De Deyn PP. Sinus sigmoideus thrombosis secondary to graves' disease: a case description. Case Reports in Neurology. 3: 203-9. PMID 22114580 DOI: 10.1159/000331448  0.52
2011 Wostyn P, Van Dam D, Audenaert K, De Deyn PP. Genes involved in cerebrospinal fluid production as candidate genes for late-onset Alzheimer's disease: A hypothesis Journal of Neurogenetics. 25: 195-200. PMID 22023247 DOI: 10.3109/01677063.2011.620191  0.52
2011 van Laar T, De Deyn PP, Aarsland D, Barone P, Galvin JE. Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data. Cns Neuroscience & Therapeutics. 17: 428-41. PMID 21951368 DOI: 10.1111/j.1755-5949.2010.00166.x  0.52
2011 De Deyn PP, Goeman J, Vervaet A, Dourcy-Belle-Rose B, Van Dam D, Geerts E. Prevalence and incidence of dementia among 75-80-year-old community-dwelling elderly in different districts of Antwerp, Belgium: the Antwerp Cognition (ANCOG) Study. Clinical Neurology and Neurosurgery. 113: 736-45. PMID 21862210 DOI: 10.1016/j.clineuro.2011.07.030  0.52
2011 Wostyn P, De Groot V, Audenaert K, De Deyn PP. Are intracranial pressure fluctuations important in glaucoma? Medical Hypotheses. 77: 598-600. PMID 21767918 DOI: 10.1016/j.mehy.2011.06.043  0.52
2011 Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nature Genetics. 43: 699-705. PMID 21685912 DOI: 10.1038/ng.859  0.52
2011 Vermeiren Y, Le Bastard N, Clark CM, Engelborghs S, De Deyn PP. Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease. Neurochemical Research. 36: 1858-62. PMID 21597934 DOI: 10.1007/s11064-011-0504-4  0.52
2011 De Smet HJ, Engelborghs S, Paquier PF, De Deyn PP, Mariën P. Cerebellar-induced apraxic agraphia: a review and three new cases. Brain and Cognition. 76: 424-34. PMID 21507544 DOI: 10.1016/j.bandc.2010.12.006  0.52
2011 Chen-Plotkin AS, Martinez-Lage M, Sleiman PM, Hu W, Greene R, Wood EM, Bing S, Grossman M, Schellenberg GD, Hatanpaa KJ, Weiner MF, White CL, Brooks WS, Halliday GM, Kril JJ, ... ... De Deyn PP, et al. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Archives of Neurology. 68: 488-97. PMID 21482928 DOI: 10.1001/archneurol.2011.53  0.52
2011 Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, ... ... De Deyn PP, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genetics. 43: 429-35. PMID 21460840 DOI: 10.1038/ng.803  0.52
2011 Gebruers N, Truijen S, Engelborghs S, De Deyn PP. Is activity loss predictive for development of upper limb oedema after stroke? Journal of Rehabilitation Medicine. 43: 398-403. PMID 21412674 DOI: 10.2340/16501977-0780  0.52
2011 Van Dijck A, Hayakawa E, Landuyt B, Baggerman G, Van Dam D, Luyten W, Schoofs L, De Deyn PP. Comparison of extraction methods for peptidomics analysis of mouse brain tissue Journal of Neuroscience Methods. 197: 231-237. PMID 21376080 DOI: 10.1016/j.jneumeth.2011.02.023  0.52
2011 Van Dam D, De Deyn PP. Animal models in the drug discovery pipeline for Alzheimer's disease British Journal of Pharmacology. 164: 1285-1300. PMID 21371009 DOI: 10.1111/j.1476-5381.2011.01299.x  0.52
2011 van der Zee J, Van Langenhove T, Kleinberger G, Sleegers K, Engelborghs S, Vandenberghe R, Santens P, Van den Broeck M, Joris G, Brys J, Mattheijssens M, Peeters K, Cras P, De Deyn PP, Cruts M, et al. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain : a Journal of Neurology. 134: 808-15. PMID 21354975 DOI: 10.1093/brain/awr007  0.52
2011 Schallier A, Smolders I, Van Dam D, Loyens E, De Deyn PP, Michotte A, Michotte Y, Massie A. Region-and age-specific changes in glutamate transport in the AβPP23 mouse model for alzheimer's disease Journal of Alzheimer's Disease. 24: 287-300. PMID 21297271 DOI: 10.3233/JAD-2011-101005  0.52
2011 Van Ginneken C, Schäfer KH, Van Dam D, Huygelen V, De Deyn PP. Morphological changes in the enteric nervous system of aging and APP23 transgenic mice. Brain Research. 1378: 43-53. PMID 21241669 DOI: 10.1016/j.brainres.2011.01.030  0.52
2011 Gebruers N, Truijen S, Engelborghs S, De Deyn PP. Incidence of upper limb oedema in patients with acute hemiparetic stroke. Disability and Rehabilitation. 33: 1791-6. PMID 21235426 DOI: 10.3109/09638288.2010.548895  0.52
2011 Geeganage C, Tracy M, England T, Sare G, Moulin T, Woimant F, Christensen H, De Deyn PP, Leys D, O'Neill D, Ringelstein EB, Bath PM. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke; a Journal of Cerebral Circulation. 42: 491-3. PMID 21183747 DOI: 10.1161/STROKEAHA.110.596163  0.52
2011 Brouns R, Wauters A, De Surgeloose D, Mariën P, De Deyn PP. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. European Neurology. 65: 23-31. PMID 21135557 DOI: 10.1159/000321965  0.52
2011 De Witte L, Brouns R, Kavadias D, Engelborghs S, De Deyn PP, Mariën P. Cognitive, affective and behavioural disturbances following vascular thalamic lesions: a review. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 47: 273-319. PMID 21111408 DOI: 10.1016/j.cortex.2010.09.002  0.52
2011 Sheorajpanday RV, Nagels G, Weeren AJ, van Putten MJ, De Deyn PP. Quantitative EEG in ischemic stroke: correlation with functional status after 6 months. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 122: 874-83. PMID 20961806 DOI: 10.1016/j.clinph.2010.07.028  0.52
2011 Dierckx E, Engelborghs S, De Raedt R, De Deyn PP, D'Haenens E, Verte D, Ponjaert-Kristoffersen I. The 10-word learning task in the differential diagnosis of early Alzheimer's disease and elderly depression: A cross-sectional pilot study. Aging & Mental Health. 15: 113-21. PMID 20924811 DOI: 10.1080/13607863.2010.505228  0.52
2011 Sheorajpanday RV, Nagels G, Weeren AJ, De Deyn PP. Quantitative EEG in ischemic stroke: correlation with infarct volume and functional status in posterior circulation and lacunar syndromes. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 122: 884-90. PMID 20870455 DOI: 10.1016/j.clinph.2010.08.020  0.52
2011 Rollinson S, Rohrer JD, van der Zee J, Sleegers K, Mead S, Engelborghs S, Collinge J, De Deyn PP, Mann DM, Van Broeckhoven C, Pickering-Brown SM. No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration. Neurobiology of Aging. 32: 754-5. PMID 19446372 DOI: 10.1016/j.neurobiolaging.2009.04.009  0.52
2011 Meeus B, Nuytemans K, Crosiers D, Engelborghs S, Pals P, Pickut B, Peeters K, Mattheijssens M, Corsmit E, Cras P, De Deyn PP, Theuns J, Van Broeckhoven C. GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population. Neurobiology of Aging. 32: 308-12. PMID 19321232 DOI: 10.1016/j.neurobiolaging.2009.02.016  0.52
2011 Wostyn P, Audenaert K, De Deyn PP. Choroidal proteins involved in cerebrospinal fluid production may be potential drug targets for alzheimer's disease therapy Perspectives in Medicinal Chemistry. 2011: 11-17. DOI: 10.4137/PMC.S6509  0.52
2011 Wostyn P, Van Dam D, Audenaert K, De Deyn PP. Increased cerebrospinal fluid production as a possible mechanism underlying caffeine's protective effect against Alzheimer's disease International Journal of Alzheimer's Disease. DOI: 10.4061/2011/617420  0.52
2011 Brouns R, Thijs V, Eyskens F, De Deyn PP. Response to letter regarding belgian Fabry study: Prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease Stroke. 42. DOI: 10.1161/STROKEAHA.110.593814  0.52
2011 Wostyn P, Audenaert K, De Deyn PP. Authors' response British Journal of Ophthalmology. 95: 152-153. DOI: 10.1136/bjo.2010.180778  0.52
2011 Van Dam D, Van Dijck A, De Deyn PP. Behavioral validation in animal models of dementia Neuromethods. 48: 143-154. DOI: 10.1007/978-1-60761-898-0_8  0.52
2011 Van Dijck A, Van Dam D, De Deyn PP. Species, strain, and gender issues in the development and validation of animal models of dementia Neuromethods. 48: 53-75. DOI: 10.1007/978-1-60761-898-0_4  0.52
2011 Van Dam D, De Deyn PP. The role of rodent models in the drug discovery pipeline for dementia Neuromethods. 48: 35-49. DOI: 10.1007/978-1-60761-898-0_3  0.52
2011 Van Dam D, De Deyn PP. APP-based transgenic models: The APP23 model Neuromethods. 48: 399-413. DOI: 10.1007/978-1-60761-898-0_20  0.52
2011 De Deyn PP, Van Dam D. General introduction to animal models of human conditions Neuromethods. 48: 3-13. DOI: 10.1007/978-1-60761-898-0_1  0.52
2011 De Deyn PP, Van Dam D. Neuromethods: Preface Neuromethods. 48.  0.52
2010 Aries MJ, Le Bastard N, Debruyne H, Van Buggenhout M, Nagels G, De Deyn PP, Engelborghs S. Relation between frontal lobe symptoms and dementia severity within and across diagnostic dementia categories. International Journal of Geriatric Psychiatry. 25: 1186-95. PMID 20957694 DOI: 10.1002/gps.2481  0.52
2010 Nguyen AT, Aerts T, Van Dam D, De Deyn PP. Biogenic amines and their metabolites in mouse brain tissue: Development, optimization and validation of an analytical HPLC method Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 878: 3003-3014. PMID 20934393 DOI: 10.1016/j.jchromb.2010.09.019  0.52
2010 Vanhooren V, Dewaele S, Libert C, Engelborghs S, De Deyn PP, Toussaint O, Debacq-Chainiaux F, Poulain M, Glupczynski Y, Franceschi C, Jaspers K, van der Pluijm I, Hoeijmakers J, Chen CC. Serum N-glycan profile shift during human ageing. Experimental Gerontology. 45: 738-43. PMID 20801208 DOI: 10.1016/j.exger.2010.08.009  0.52
2010 De Meyer G, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Archives of Neurology. 67: 949-56. PMID 20697045 DOI: 10.1001/archneurol.2010.179  0.52
2010 Wostyn P, Audenaert K, De Deyn PP. High occurrence rate of glaucoma among patients with normal pressure hydrocephalus Journal of Glaucoma. 19: 225-226. PMID 20625253  0.52
2010 Brouwers N, Bettens K, Gijselinck I, Engelborghs S, Pickut BA, Van Miegroet H, Montoya AG, Mattheijssens M, Peeters K, De Deyn PP, Cruts M, Sleegers K, Van Broeckhoven C. Contribution of TARDBP to Alzheimer's disease genetic etiology. Journal of Alzheimer's Disease : Jad. 21: 423-30. PMID 20555136 DOI: 10.3233/JAD-2010-100198  0.52
2010 Brouns R, Verkerk R, Aerts T, De Surgeloose D, Wauters A, Scharpé S, De Deyn PP. The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke. Neurochemical Research. 35: 1315-22. PMID 20490917 DOI: 10.1007/s11064-010-0187-2  0.52
2010 Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, Seelaar H, Van Swieten JC, Brown JM, Johannsen P, Nielsen JE, Holm IE, Dickson DW, Rademakers R, ... ... De Deyn PP, et al. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathologica. 120: 33-41. PMID 20490813 DOI: 10.1007/s00401-010-0698-6  0.52
2010 Mariën P, Wackenier P, De Surgeloose D, De Deyn PP, Verhoeven J. Developmental coordination disorder: disruption of the cerebello-cerebral network evidenced by SPECT. Cerebellum (London, England). 9: 405-10. PMID 20461488 DOI: 10.1007/s12311-010-0177-6  0.52
2010 Gijselinck I, Engelborghs S, Maes G, Cuijt I, Peeters K, Mattheijssens M, Joris G, Cras P, Martin JJ, De Deyn PP, Kumar-Singh S, Van Broeckhoven C, Cruts M. Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Archives of Neurology. 67: 606-16. PMID 20457961 DOI: 10.1001/archneurol.2010.82  0.52
2010 Chen CC, Engelborghs S, Dewaele S, Le Bastard N, Martin JJ, Vanhooren V, Libert C, De Deyn PP. Altered serum glycomics in Alzheimer disease: a potential blood biomarker? Rejuvenation Research. 13: 439-44. PMID 20426627 DOI: 10.1089/rej.2009.0992  0.52
2010 Le Bastard N, Leurs J, Blomme W, De Deyn PP, Engelborghs S. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients. Journal of Alzheimer's Disease : Jad. 21: 291-301. PMID 20421698 DOI: 10.3233/JAD-2010-091501  0.52
2010 Bettens K, Brouwers N, Van Miegroet H, Gil A, Engelborghs S, De Deyn PP, Vandenberghe R, Van Broeckhoven C, Sleegers K. Follow-up study of susceptibility loci for Alzheimer's disease and onset age identified by genome-wide association. Journal of Alzheimer's Disease : Jad. 19: 1169-75. PMID 20308783 DOI: 10.3233/JAD-2010-1310  0.52
2010 Gonsette RE, Sindic C, D'Hooghe MB, De Deyn PP, Medaer R, Michotte A, Seeldrayers P, Guillaume D. Boosting endogenous neuroprotection in multiple sclerosis: The ASsociation of inosine and interferon β in relapsing-remitting multiple sclerosis (ASIIMS) trial Multiple Sclerosis. 16: 455-462. PMID 20200198 DOI: 10.1177/1352458509360547  0.52
2010 Sheorajpanday RV, Nagels G, Weeren AJ, De Surgeloose D, De Deyn PP. Additional value of quantitative EEG in acute anterior circulation syndrome of presumed ischemic origin. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 121: 1719-25. PMID 20181521 DOI: 10.1016/j.clinph.2009.10.037  0.52
2010 Meeus B, Nuytemans K, Crosiers D, Engelborghs S, Peeters K, Mattheijssens M, Elinck E, Corsmit E, De Deyn PP, Van Broeckhoven C, Theuns J. Comprehensive genetic and mutation analysis of familial dementia with lewy bodies linked to 2q35-q36 Journal of Alzheimer's Disease. 20: 197-205. PMID 20164589 DOI: 10.3233/JAD-2010-1356  0.52
2010 Gebruers N, Vanroy C, Truijen S, Engelborghs S, De Deyn PP. Monitoring of physical activity after stroke: a systematic review of accelerometry-based measures. Archives of Physical Medicine and Rehabilitation. 91: 288-97. PMID 20159136 DOI: 10.1016/j.apmr.2009.10.025  0.52
2010 Wostyn P, Audenaert K, De Deyn PP. Alzheimer's disease: Cerebral glaucoma? Medical Hypotheses. 74: 973-977. PMID 20056337 DOI: 10.1016/j.mehy.2009.12.019  0.52
2010 Brouns R, Van Hemelrijck A, Drinkenburg WH, Van Dam D, De Surgeloose D, De Deyn PP. Excitatory amino acids and monoaminergic neurotransmitters in cerebrospinal fluid of acute ischemic stroke patients. Neurochemistry International. 56: 865-70. PMID 20036703 DOI: 10.1016/j.neuint.2009.12.014  0.52
2010 Brouns R, Heylen E, Willemse JL, Sheorajpanday R, De Surgeloose D, Verkerk R, De Deyn PP, Hendriks DF. The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome. Journal of Thrombosis and Haemostasis : Jth. 8: 75-80. PMID 19874466 DOI: 10.1111/j.1538-7836.2009.03663.x  0.52
2010 Baillieux H, De Smet HJ, Dobbeleir A, Paquier PF, De Deyn PP, Mariën P. Cognitive and affective disturbances following focal cerebellar damage in adults: a neuropsychological and SPECT study. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 46: 869-79. PMID 19853848 DOI: 10.1016/j.cortex.2009.09.002  0.52
2010 Le Bastard N, Martin JJ, Vanmechelen E, Vanderstichele H, De Deyn PP, Engelborghs S. Added diagnostic value of CSF biomarkers in differential dementia diagnosis. Neurobiology of Aging. 31: 1867-76. PMID 19150153 DOI: 10.1016/j.neurobiolaging.2008.10.017  0.52
2010 Babiloni C, Visser PJ, Frisoni G, De Deyn PP, Bresciani L, Jelic V, Nagels G, Rodriguez G, Rossini PM, Vecchio F, Colombo D, Verhey F, Wahlund LO, Nobili F. Cortical sources of resting EEG rhythms in mild cognitive impairment and subjective memory complaint Neurobiology of Aging. 31: 1787-1798. PMID 19027196 DOI: 10.1016/j.neurobiolaging.2008.09.020  0.52
2010 Van Dam D, Coen K, De Deyn PP. Ibuprofen modifies cognitive disease progression in an Alzheimer's mouse model Journal of Psychopharmacology. 24: 383-388. PMID 18957478 DOI: 10.1177/0269881108097630  0.52
2010 Van Dijck A, Van Dam D, Vergote V, De Spiegeleer B, Luyten W, Schoofs L, De Deyn PP. Corrigendum to "Central administration of obestatin fails to show inhibitory effects on food and water intake in mice" [Regul Pept 156 (2009) 77-82] Regulatory Peptides. 163: 143. DOI: 10.1016/j.regpep.2010.01.002  0.52
2010 Brouns R, De Deyn PP. Neurological problems Management of Acute Kidney Problems. 197-207. DOI: 10.1007/978-3-540-69441-0_21  0.52
2009 De Smet HJ, Baillieux H, Wackenier P, De Praeter M, Engelborghs S, Paquier PF, De Deyn PP, Mariën P. Long-term cognitive deficits following posterior fossa tumor resection: a neuropsychological and functional neuroimaging follow-up study. Neuropsychology. 23: 694-704. PMID 19899828 DOI: 10.1037/a0016106  0.52
2009 Bettens K, Brouwers N, Engelborghs S, Van Miegroet H, De Deyn PP, Theuns J, Sleegers K, Van Broeckhoven C. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. Human Mutation. 30: 1207-13. PMID 19462468 DOI: 10.1002/humu.21027  0.52
2009 Brouns R, Marescau B, Possemiers I, Sheorajpanday R, De Deyn PP. Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. Neurochemical Research. 34: 1642-9. PMID 19296217 DOI: 10.1007/s11064-009-9954-3  0.52
2009 Sleegers K, Brouwers N, Bettens K, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population. Human Mutation. 30: E570-4. PMID 19191332 DOI: 10.1002/humu.20990  0.52
2009 Mariën P, Verhoeven J, Wackenier P, Engelborghs S, De Deyn PP. Foreign accent syndrome as a developmental motor speech disorder. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 45: 870-8. PMID 19121521 DOI: 10.1016/j.cortex.2008.10.010  0.52
2009 Baillieux H, Vandervliet EJ, Manto M, Parizel PM, De Deyn PP, Mariën P. Developmental dyslexia and widespread activation across the cerebellar hemispheres. Brain and Language. 108: 122-32. PMID 18986695 DOI: 10.1016/j.bandl.2008.10.001  0.52
2009 Sleegers K, Bettens K, Brouwers N, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C. Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia. Human Mutation. 30: E338-44. PMID 18853460 DOI: 10.1002/humu.20909  0.52
2008 De Witte L, Verhoeven J, Engelborghs S, De Deyn PP, Mariën P. Crossed aphasia and visuo-spatial neglect following a right thalamic stroke: a case study and review of the literature. Behavioural Neurology. 19: 177-94. PMID 19096142  0.52
2008 Bogaerts V, Nuytemans K, Reumers J, Pals P, Engelborghs S, Pickut B, Corsmit E, Peeters K, Schymkowitz J, De Deyn PP, Cras P, Rousseau F, Theuns J, Van Broeckhoven C. Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease. Human Mutation. 29: 832-40. PMID 18401856 DOI: 10.1002/humu.20713  0.52
2008 Willemse JL, Brouns R, Heylen E, De Deyn PP, Hendriks DF. Carboxypeptidase U (TAFIa) activity is induced in vivo in ischemic stroke patients receiving thrombolytic therapy. Journal of Thrombosis and Haemostasis : Jth. 6: 200-2. PMID 17944994 DOI: 10.1111/j.1538-7836.2007.02798.x  0.52
2007 De Smet HJ, Baillieux H, Catsman-Berrevoets C, De Deyn PP, Mariën P, Paquier PF. Postoperative motor speech production in children with the syndrome of 'cerebellar' mutism and subsequent dysarthria: a critical review of the literature. European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society. 11: 193-207. PMID 17320435 DOI: 10.1016/j.ejpn.2007.01.007  0.52
2005 Van Dam D, Vloeberghs E, Abramowski D, Staufenbiel M, De Deyn PP. APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder. Cns Spectrums. 10: 207-22. PMID 15744222 DOI: 10.1017/S1092852900010051  0.48
2004 Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, et al. Rivastigmine for dementia associated with Parkinson's disease. The New England Journal of Medicine. 351: 2509-18. PMID 15590953 DOI: 10.1056/NEJMoa041470  0.52
2003 Storms G, Dirikx T, Saerens J, Verstraeten S, De Deyn PP. On the use of scaling and clustering in the study of semantic deficits Neuropsychology. 17: 289-301. PMID 12803435 DOI: 10.1037/0894-4105.17.2.289  0.52
Show low-probability matches.